Fidus Investment Corporation (FDUS)

Blueprint Medicines Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	719	713	560	465	439	320
Market Cap Growth	17.06%	27.25%	20.47%	5.84%	37.25%	-11.82%
Enterprise Value	1,185	1,130	925	815	693	639
Last Close Price	20.53	19.94	16.54	13.78	11.77	7.81
PE Ratio	8.81	9.11	7.26	12.98	3.78	10.25
Forward PE	10.16	9.86	8.43	9.00	11.66	9.06
PS Ratio	4.63	4.88	4.31	4.94	4.86	3.76
PB Ratio	1.06	1.09	0.95	0.97	0.90	0.78
P/TBV Ratio	1.06	1.09	0.95	0.97	0.90	0.78
P/OCF Ratio	-	-	-	-	2.62	5.72
PEG Ratio	-	5.34	5.34	5.34	5.34	5.34
EV/Sales Ratio	8.01	7.73	7.11	8.66	7.66	7.51
EV/EBIT Ratio	11.53	11.14	10.41	12.23	15.47	10.69
Debt / Equity Ratio	0.79	0.72	0.79	0.85	0.75	1.08
Asset Turnover	0.13	0.13	0.13	0.10	0.10	0.10
Quick Ratio	2.89	2.15	3.76	1.63	4.10	6.07
Current Ratio	2.92	2.19	3.81	1.66	4.10	6.12
Return on Equity (ROE)	12.10%	12.58%	14.42%	7.40%	25.84%	7.59%
Return on Assets (ROA)	5.51%	5.63%	5.48%	4.54%	3.16%	4.49%
Return on Capital (ROIC)	5.65%	5.80%	5.71%	4.78%	3.28%	4.61%
Return on Capital Employed (ROCE)	8.50%	9.00%	8.40%	7.50%	5.20%	7.00%
Earnings Yield	10.83%	10.98%	13.77%	7.70%	26.42%	9.75%
Dividend Yield	11.01%	8.63%	10.04%	10.45%	10.70%	16.51%
Payout Ratio	97.02%	71.17%	58.29%	98.52%	26.52%	100.97%
Buyback Yield / Dilution	-19.93%	-23.59%	-7.75%	-0.13%	0.02%	0.08%
Total Shareholder Return	-8.92%	-14.97%	2.28%	10.32%	10.72%	16.60%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q